Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19: a Randomized, Double-blind, Placebo-controlled Trial

NCT04795557 is registered in ClinicalTrials.gov with Swedish Herbal Institute AB as lead sponsor.

NCT NCT04795557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19: a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Swedish Herbal Institute AB
Phase
Phase 2/3
Overall status
Completed
Start date
April 19, 2021
Completion date
December 26, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19